These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20590699)

  • 1. Progressive interstitial fibrosis of kidney allograft early after transplantation from a non-heart beating donor: possible role of persistent ischemic injury.
    Masutani K; Kitada H; Yamada S; Tsuchimoto A; Noguchi H; Tsuruya K; Katafuchi R; Tanaka M; Iida M
    Clin Transplant; 2010 Jul; 24 Suppl 22():70-4. PubMed ID: 20590699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report.
    Tanabe T; Shimizu T; Sai K; Miyauchi Y; Shirakawa H; Ishida H; Honda K; Koike J; Yamaguchi Y; Tanabe K
    Clin Transplant; 2011 Jul; 25 Suppl 23():39-43. PubMed ID: 21623913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful kidney transplantation from a cadaveric donor unsuitable for other centers due to acute renal failure: a case report.
    Bilgic A; Erdogan B; Kali A; Buyukbakkal M; Eser B; Bozkurt B; Kilic M; Ayli MD
    Transplant Proc; 2012; 44(6):1764-6. PubMed ID: 22841267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts.
    Oda A; Morozumi K; Uchida K
    Clin Transplant; 1999; 13 Suppl 1():6-12. PubMed ID: 10751050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different clinicopathological courses of two recipients of kidneys retrieved from the same non-heart beating donor.
    Nishikido M; Noguchi M; Koga S; Kanetake H; Harada T; Taguchi T; Watanabe J; Matsuya F; Hayashi M
    Clin Transplant; 2004; 18 Suppl 11():54-60. PubMed ID: 15191375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult dual kidney transplantations obtained from marginal donors: two case reports.
    Kim YH; Jung JH; Song KB; Chung YS; Park JB; Cho YM; Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2012 Jan; 44(1):57-9. PubMed ID: 22310578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function.
    Dikow R; Becker LE; Schaier M; Waldherr R; Gross ML; Zeier M
    Transplantation; 2010 Oct; 90(7):771-6. PubMed ID: 20697328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor affected by hemosiderosis: is kidney transplantation possible? A case report.
    Piattoni J; Bonucchi D; Gissara Z; Baisi B; Cappelli G
    Transplant Proc; 2008; 40(6):1827-8. PubMed ID: 18675062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for prolonged hospitalization after kidney transplants.
    Matas AJ; Gillingham KJ; Elick BA; Dunn DL; Gruessner RW; Payne WD; Sutherland DE; Najarian JS
    Clin Transplant; 1997 Aug; 11(4):259-64. PubMed ID: 9267712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy.
    Atsumi H; Asaka M; Kimura S; Imura J; Fujimoto K; Chikazawa Y; Nakagawa M; Okuyama H; Yamaya H; Moriyama M; Tanaka T; Suzuki K; Yokoyama H
    Clin Transplant; 2010 Jul; 24 Suppl 22():35-8. PubMed ID: 20590692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors.
    Bains JC; Sandford RM; Brook NR; Hosgood SA; Lewis GR; Nicholson ML
    Br J Surg; 2005 Jan; 92(1):113-8. PubMed ID: 15593295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.
    Jung GO; Yoon MR; Kim SJ; Sin MJ; Kim EY; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Lee SK
    Transplant Proc; 2010 Apr; 42(3):705-9. PubMed ID: 20430152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the development of delayed graft function in deceased donor renal transplants.
    Jushinskis J; Trushkov S; Bicans J; Suhorukov V; Shevelev V; Ziedina I; Rozental R
    Transplant Proc; 2009 Mar; 41(2):746-8. PubMed ID: 19328971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.